Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1976 1
1979 2
1980 1
1982 2
1983 2
1984 3
1985 3
1986 2
1987 2
1988 3
1989 1
1991 1
1992 3
1993 2
1994 3
1996 1
1997 9
1998 4
1999 1
2000 3
2001 3
2002 4
2004 7
2005 6
2006 9
2007 5
2008 6
2009 7
2010 5
2011 5
2012 3
2013 5
2014 11
2015 7
2016 20
2017 11
2018 8
2019 9
2020 10
2021 5
2022 1
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Regressing Cutaneous Melanoma"
Page 1
Androgen receptor is a determinant of melanoma targeted drug resistance.
Samarkina A, Youssef MK, Ostano P, Ghosh S, Ma M, Tassone B, Proust T, Chiorino G, Levesque MP, Goruppi S, Dotto GP. Samarkina A, et al. Nat Commun. 2023 Oct 14;14(1):6498. doi: 10.1038/s41467-023-42239-w. Nat Commun. 2023. PMID: 37838724 Free PMC article.
Melanoma provides a primary benchmark for targeted drug therapy. Most melanomas with BRAF(V600) mutations regress in response to BRAF/MEK inhibitors (BRAFi/MEKi). ...Our findings point to targeting AR as possible co-therapeutical approach in melanoma treatmen …
Melanoma provides a primary benchmark for targeted drug therapy. Most melanomas with BRAF(V600) mutations regress in response …
Skin Cancer: Precancers.
Bruner P, Bashline B. Bruner P, et al. FP Essent. 2019 Jun;481:23-27. FP Essent. 2019. PMID: 31188549
Rates of lesion progression to squamous cell carcinoma (SCC) have been reported to be between 0.025% and 16%, some lesions may regress. Atypical moles are melanocytic nevi that indicate a higher risk of melanoma and, on rare occasions, transform into malignant …
Rates of lesion progression to squamous cell carcinoma (SCC) have been reported to be between 0.025% and 16%, some lesions may regress …
The regenerating naevus.
Vilain RE, McCarthy SW, Scolyer RA. Vilain RE, et al. Pathology. 2016 Feb;48(2):108-12. doi: 10.1016/j.pathol.2015.12.009. Epub 2016 Jan 13. Pathology. 2016. PMID: 27020383
These lesions can adopt an appearance which may be impossible to confidently distinguish from a regressing or traumatised melanoma on histological grounds alone. For this reason, careful attention must be paid to the clinical context which has given rise to the lesi …
These lesions can adopt an appearance which may be impossible to confidently distinguish from a regressing or traumatised melanoma …
Familial melanoma.
Newton JA. Newton JA. Clin Exp Dermatol. 1993 Jan;18(1):5-11. doi: 10.1111/j.1365-2230.1993.tb00956.x. Clin Exp Dermatol. 1993. PMID: 8440053 Review.
The presence of this phenotype indicates an increased risk of melanoma, although the risk varies according to the presence or absence of a family history. ...The vast majority of these probably regress as do totally banal naevi, although a low percentage will result …
The presence of this phenotype indicates an increased risk of melanoma, although the risk varies according to the presence or absence …
Dermoscopy-pathology relationship in seborrheic keratosis.
Minagawa A. Minagawa A. J Dermatol. 2017 May;44(5):518-524. doi: 10.1111/1346-8138.13657. J Dermatol. 2017. PMID: 28447350 Review.
Clinicians should bear in mind that the clonal type of SK dermoscopically mimics melanoma and BCC by the presence of globule-like structures, while regressing SK exhibits a granular pattern that is similar to the peppering found in melanoma. Furthermore, mili …
Clinicians should bear in mind that the clonal type of SK dermoscopically mimics melanoma and BCC by the presence of globule-like str …
Regression in cutaneous melanoma: a comprehensive review from diagnosis to prognosis.
Ribero S, Moscarella E, Ferrara G, Piana S, Argenziano G, Longo C. Ribero S, et al. J Eur Acad Dermatol Venereol. 2016 Dec;30(12):2030-2037. doi: 10.1111/jdv.13815. Epub 2016 Jul 12. J Eur Acad Dermatol Venereol. 2016. PMID: 27401335 Review.
Histological regression in primary cutaneous melanoma occurs in 10-35% of cases. Although a large body of literature exists to suggest that histological regression serves very little purpose in predicting biologic behaviour with melanoma, recognizing the pres …
Histological regression in primary cutaneous melanoma occurs in 10-35% of cases. Although a large body of literature exists to …
Skin tumors in childhood.
Hamm H, Höger PH. Hamm H, et al. Dtsch Arztebl Int. 2011 May;108(20):347-53. doi: 10.3238/arztebl.2011.0347. Epub 2011 May 20. Dtsch Arztebl Int. 2011. PMID: 21655460 Free PMC article. Review.
Warning signs of malignancy include rapid growth, firm consistency, diameter exceeding 3 cm, ulceration, a non-movable mass, and presence in the neonatal period. The more common malignant skin tumors in adults-basal cell carcinoma, cutaneous squamous cell carcinoma, …
Warning signs of malignancy include rapid growth, firm consistency, diameter exceeding 3 cm, ulceration, a non-movable mass, and presence in …
Therapy-induced tumour secretomes promote resistance and tumour progression.
Obenauf AC, Zou Y, Ji AL, Vanharanta S, Shu W, Shi H, Kong X, Bosenberg MC, Wiesner T, Rosen N, Lo RS, Massagué J. Obenauf AC, et al. Nature. 2015 Apr 16;520(7547):368-72. doi: 10.1038/nature14336. Epub 2015 Mar 25. Nature. 2015. PMID: 25807485 Free PMC article.
The tumour-promoting secretome of melanoma cells treated with the kinase inhibitor vemurafenib is driven by downregulation of the transcription factor FRA1. In situ transcriptome analysis of drug-resistant melanoma cells responding to the regressing tumour mi …
The tumour-promoting secretome of melanoma cells treated with the kinase inhibitor vemurafenib is driven by downregulation of the tra …
An update on cutaneous melanoma in Turkey: evaluation of 19-year data in a single tertiary centre and review of the literature.
Baykal C, Atci T, Polat Ekinci A, Buyukbabani N. Baykal C, et al. J Eur Acad Dermatol Venereol. 2017 Feb;31(2):236-240. doi: 10.1111/jdv.13866. Epub 2016 Aug 13. J Eur Acad Dermatol Venereol. 2017. PMID: 27519285 Review.
RESULTS: There were 227 patients with melanoma showing five different clinical presentations: 200 of them had totally 207 primary cutaneous melanoma (PCM) lesions, nine had PCM lesions associated with metastatic skin lesions, three presented with local recurr …
RESULTS: There were 227 patients with melanoma showing five different clinical presentations: 200 of them had totally 207 primary …
VITREOUS SEEDING OF CHOROIDAL MELANOMA.
Raval V, Bowen RC, Soto H, Biscotti C, Yeaney G, Sears J, Singh A. Raval V, et al. Retina. 2021 Apr 1;41(4):890-894. doi: 10.1097/IAE.0000000000002989. Retina. 2021. PMID: 33009220 Review.
Over the next 9 months, the vitreous hemorrhage cleared and choroidal melanoma with retinal invasion became evident. One year after brachytherapy, the primary tumor regressed with resolution of surrounding subretinal fluid and hemorrhage. ...CONCLUSION: Vitreous see …
Over the next 9 months, the vitreous hemorrhage cleared and choroidal melanoma with retinal invasion became evident. One year after b …
191 results